This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Linz, W. Articles by Wiemer, G. Search for Related Content PubMed PubMed Citation Articles by Linz, W. Articles by Wiemer, G. Social Bookmarking                         What's this?

Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction

Aventis Pharma Deutschland GmbH, DG Cardiovascular Diseases, D-65926 Frankfurt/Main, Germany, Wolfgang.Linz{at}aventis.com

Gabi Itter

Aventis Pharma Deutschland GmbH, DG Cardiovascular Diseases, D-65926 Frankfurt/Main, Germany

Lawrence W Dobrucki

Ohio University, Department of Chemistry and Biochemistry, Athens, OH 45701-2979, USA

Tadeusz Malinski

Ohio University, Department of Chemistry and Biochemistry, Athens, OH 45701-2979, USA

Gabriele Wiemer

Aventis Pharma Deutschland GmbH, DG Cardiovascular Diseases, D-65926 Frankfurt/Main, Germany

A markedly decreased aortic nitric oxide (NO) availability, probably due to impaired endothelial nitric oxide synthase activity with enhanced O₂- and peroxynitrite production, seems to be attributable to endothelial dysfunction in spontaneously hypertensive rats (SHR) with severe congestive heart failure (CHF). In this study, we investigated the chronic effect of the angiotensin-converting enzyme inhibitor, ramipril (RA) and the loop diuretic, frusemide (FU), as well as the combination of both on endothelial NO, O₂- and peroxynitrite production in aortae from SHR with failing hearts after myocardial infarction (MI).

Heart failure was induced by permanent occlusion of the left coronary artery. SHR were randomised to receive either placebo, RA, (1 mg/kg/day), FU (4 mg/kg/day) or RA+FU (1 and 4 mg/kg/day, respectively). Treatments were started two weeks following MI and continued for six weeks. Reduced aortic and coronary flow indices in the working heart, which can be considered as markers for endothelial function, were significantly normalised and improved, respectively, by RA, FU or RA+FU-treatment. Similarly, all three treatment regimens significantly enhanced the reduced calcium ionophore (CaI)-induced NO-release (assessed by a NO-sensitive microsensor) from aortic endothelial cells of placebo- treated animals with CHF. Concomitantly, the increased CaI-stimulated O ₂production (assessed by an electrochemical sensor) in aortic endothelial cells of placebo-treated animals with CHF was significantly reduced by RA and RA+FUtreatment. Treatment with RA and RA+FU also attenuated the dramatic increase in endothelial peroxynitrite concentration (chemiluminescence method), which was observed in placebo-treated rats with CHF. FU did not counteract improved haemo- and cardiodynamic parameters by RA.

Thus, RA and FU act synergistically to enhance bioavailability of endothelium-derived NO, and this may contribute to the clinical usefulness of the combination of these drugs in treatment of heart failure.

Key Words: congestive heart failure • ramipril • frusemide • nitric oxide • superoxide • spontaneously hypertensive rats

References

• Drexler H., Hayoz D., Münzel T. et al. Endothelial function in chronic heart failure. Am J Cardiol 1992;69:1596-601.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Katz SD, Biasucci L., Sabba C. et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992;19:918-25.[Abstract]
• Kaiser L., Spickard RC, Olivier NB Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol 1989;256:H962-H967.[Web of Science][Medline] [Order article via Infotrieve]
• Drexler H., Lu W. Endothelial dysfunction in hindquarter resistance vessels in experimental heart failure. Am J Physiol 1992;262:H1640-H1645.[Web of Science][Medline] [Order article via Infotrieve]
• Wiemer G., Itter G., Malinski T., Linz W. Decreased nitric oxide availability in normotensive and hypertensive rats with failing hearts after myocardial infarction. Hypertension 2001;38:1367-71.[Abstract/Free Full Text]
• Bauersachs J., Bouloumie A., Fraccarollo D., Hu K., Busse R., Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression. Circulation 1999;100:292-8.[Abstract/Free Full Text]
• Bauersachs J., Fleming I., Fraccarollo D., Busse R., Ertl G. Prevention of endothelial dysfunction in heart failure by vitamin E: attenuation of vascular superoxide anion formation and increase in soluble guanylyl cyclase expression. Cardiovasc Res 2001;51:344-50.[Abstract/Free Full Text]
• Katz SD, Khan T., Zeballos GA et al. Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. Circulation 1999;99:2113-17.[Abstract/Free Full Text]
• Pinsky DJ, Patton S., Mesaros S. et al. Mechanical transduction of nitric oxide in the beating heart. Circ Res 1997;81:372-9.[Abstract/Free Full Text]
• Balligand JL, Kobzik L., Han X. et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 1995;270:14582-6.[Abstract/Free Full Text]
• Vila-Petroff MG, Younes A., Egan J., Lakatta EG, Sollott SJ Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 1999; 84:1020-31.[Abstract/Free Full Text]
• Drexler H. Nitric oxide synthases in the failing human heart. Circulation 1999;99:2972-5.[Free Full Text]
• Hajjar RJ, Schwinger RHG, Schmidt U. et al. Myofilament calcium regulation in human myocardium. Circulation 2000; 101:1679-85.[Abstract/Free Full Text]
• SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.[Abstract]
• Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais D. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients: the heart outcomes prevention evaluation (HOPE) study investigators. Engl J Med 2000;342:145-53.[Abstract/Free Full Text]
• Mulder P., Elfertak L., Richard V. et al. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Am J Physiol 1996;271:H469-H477.[Web of Science][Medline] [Order article via Infotrieve]
• Mulder P., Devaux B., Richard V. et al. Early versus delayed angiotensin converting enzyme inhibition in experimental chronic heart failure. Circulation 1997;95:1314-19.[Abstract/Free Full Text]
• Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985;57:84-95.[Abstract/Free Full Text]
• Richer C., Mulder P. Fornes P., Domergue V., Heudes D., Giudicelli JF Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats.JCardiovasc Pharmacol 1992;20:147-56.[Web of Science][Medline] [Order article via Infotrieve]
• Linz W., Wohlfart P., Sckölkens BA, Malinski T., Wiemer G. Interactions among ACE, kinins and NO. Cardiovasc Res 1999;43:549-61.[Free Full Text]
• Toyoshima H., Nasa Y., Kohsaka Y. et al.The effect of chronic treatment with trandolapril on cyclic AMP and cyclic GMPdependent relaxations in aortic segments of rats with chronic heart failure. Br J Pharmacol 1998;123:344-52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Varin R., Mulder P.,Tamoin F. et al. Improvement of endothelial function by chronic angiotensin converting enzyme inhibition in heart failure. Circulation 2000;102.351-6.[Abstract/Free Full Text]
• Lundergran CF, Fitzpatrick TM, Rose JC, Ramwell PW, Kot PA Effect of cyclooxygenase inhibition on the pulmonary vasodilator response to furosemide. J Pharmacol Exp Ther 1988;246:102-06.[Abstract/Free Full Text]
• Tiam R., Aalkjer C., Andreasen F. Mechanisms behind the relaxing effect of furosemide on the isolated rabbit ear artery. Pharmacol Toxicol 1991;68:406-10.
• Wiemer G., Fink E., Linz W., Hropot M., Schölkens BA, Wohlfart P. Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin. J Pharmacol Exp Ther 1994;271:1611-15.[Abstract/Free Full Text]
• Murphey LJ, Kumar S., Brown NJ Endogenous bradykinin and the renin and pressor responses to furosemide in humans. J Pharmacol Exp Ther 2000;295:644-8.[Abstract/Free Full Text]
• Linz W., Wohlfart P., Sckölkens BA, Becker RHA, Malinski T., Wiemer G. Late treatment with ramipril increases survival in old spontaneously hypertensive rats. Hypertension 1999;34: 291-5.[Abstract/Free Full Text]
• Itter G., Linz W., Jung W., Juretschke P., Wiemer G., Schölkens BA Severe symptomatic heart failure in spontaneously hypertensive rats. Hypertension 1998;32:Abstract 807.
• Malinski T., Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 1992;358:676-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Malinski T., Czuchajowski L. Nitric oxide measurements by electrochemical methods. In: Feelish M, Stamler JS (eds.). Methods of Nitric Oxide Research. New York, NY: John Wiley & Sons, Inc. 1996;319-39.
• Lvovich V., Scheeline A. Amperometric sensors for simultaneous superoxide and hydrogen peroxide detection. Anal Chem 1997;69:454-62.
• Mesaros S.,Vankova Z., Grunfeld S., Mesarosova A., Malinski T. Preparation and optimization of superoxide microsensor. Anal Chim Acta 1998;358:27-31.[CrossRef][Web of Science]
• Grow JP, Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: Implications for intracellular measurement of reactive nitrogen and oxygen and chemistry. Nitric Oxide 1997;1:145-57.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wiemer G., Linz W., Hatrik S., Schölkens BA, Malinski T. Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats. Hypertension 1997;30:1183-90.[Abstract/Free Full Text]
• Rajagopalan S., Kurz S., Münzel T. et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH activation. J Clin Invest 1996;97:1916-23.[Web of Science][Medline] [Order article via Infotrieve]
• Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.[Abstract/Free Full Text]
• Wollert HC, Studer R., von Bülow B., Drexler H. Survival after myocardial infarction in the rat: role of tissue angiotensin converting enzyme inhibition. Circulation 1994;90:2457-67.[Abstract/Free Full Text]
• Indik JH, Goldman S., Gaballa MA Oxidative stress contributes to vascular endothelial dysfunction in heart failure. Am J Physiol Circ Physiol 2001;281:H1767-H1770.
• Hornig B., Landmesser U., Kohler C. et al. Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease. Circulation 2001;103:799-805.[Abstract/Free Full Text]
• Linz W., Jessen T., Becker RHA, Schölkens BA, Wiemer G. Long-term ACE Inhibition doubles lifespan of hypertensive rats. Circulation 1997;96:3164-72.[Abstract/Free Full Text]
• Shah AM, Lewis MJ, Henderson AH Effects of 8-bromocyclic GMP on contraction and on inotropic response of ferret cardiac muscle. J Mol Cell Cardiol 1991;23:55-64.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Seeland U., Kouchi I., Zolk O., Itter G., Linz W., Böhm M. Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts. J Mol Cell Cardiol 2002;34:151-63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kim S., HamaguchiA., ShinkawaT. et al. Molecular effects of MI7055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats. J Pharmacol Exp Ther 1996; 279:983-90.[Abstract/Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 4, No. 3, 180-185 (2003)
DOI: 10.3317/jraas.2003.029


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF]

				P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Linz, W. Articles by Wiemer, G. Search for Related Content PubMed PubMed Citation Articles by Linz, W. Articles by Wiemer, G. Social Bookmarking                         What's this?